GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vuno 338220.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

5,980

+2.57%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩34.85bn

FY2017FY2025

Net income

−₩5.78bn

FY2017FY2025

Free cash flow

−₩5.75bn

FY2017FY2025

Shareholders' equity

₩36.11bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₩34.85bn₩25.87bn₩13.28bn₩8.27bn₩2.25bn₩1.26bn₩162.1m₩82.4m₩161.8m
Research and development₩5.91bn₩5.27bn₩4.65bn₩4.85bn₩5.07bn₩2.40bn———
Operating income−₩5.42bn−₩12.53bn−₩18.91bn−₩15.52bn−₩19.79bn−₩9.72bn−₩6.02bn−₩2.67bn−₩912.6m
Net income−₩5.78bn−₩13.02bn−₩15.63bn−₩15.66bn−₩19.56bn−₩11.11bn−₩5.91bn−₩5.75bn−₩862.1m
Diluted earnings per share-412.77-937.37-1,365.12-1,376.31-1,744.70-1,237.39-658.60-640.70-96.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₩50.39bn₩50.18bn₩22.56bn₩35.38bn₩35.61bn₩9.59bn₩7.45bn₩12.47bn₩2.66bn
Cash and short-term investments———₩20.86bn₩23.12bn₩6.19bn₩5.01bn₩11.68bn₩1.99bn
Total liabilities₩14.27bn₩19.49bn₩17.54bn₩16.69bn₩13.01bn₩13.23bn₩2.03bn₩1.50bn₩8.38bn
Debt—₩1.20bn₩3.40bn₩11.84bn₩8.18bn₩10.54bn₩335.0m₩305.0m₩7.95bn
Shareholders' equity₩36.11bn₩30.69bn₩5.02bn₩18.69bn₩22.59bn−₩3.64bn₩5.42bn₩10.98bn−₩5.72bn
Shares outstanding14m14m11m11m11m9m9m9m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−₩4.68bn−₩10.86bn−₩15.55bn−₩16.28bn−₩14.80bn−₩7.80bn−₩4.87bn−₩1.75bn−₩873.1m
Capital spending−₩1.07bn−₩1.11bn−₩382.4m−₩312.5m−₩1.29bn−₩321.1m−₩715.1m−₩120.2m−₩74.6m
Free cash flow−₩5.75bn−₩11.96bn−₩15.93bn−₩16.59bn−₩16.09bn−₩8.12bn−₩5.58bn−₩1.87bn−₩947.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩6.11bn₩6.05bn₩7.23bn₩10.82bn₩9.25bn₩7.54bn₩7.08bn₩6.87bn
Operating income—−₩4.11bn—₩1.12bn−₩725.8m−₩3.43bn−₩2.94bn−₩2.70bn
Net income−₩5.38bn−₩3.99bn−₩2.71bn₩1.03bn−₩817.3m−₩3.29bn−₩3.07bn−₩2.84bn
Diluted earnings per share-384.51-284.82-193.5473.85-58.37-234.74-219.57-204.31
Cash from operations−₩4.36bn−₩2.73bn−₩686.0m−₩1.80bn−₩26.22bn₩24.03bn−₩2.85bn−₩2.01bn
Capital spending−₩626.0m−₩415.0m−₩295.0m−₩207.0m−₩360.0m−₩205.0m−₩253.0m−₩461.0m
Free cash flow−₩4.99bn−₩3.15bn−₩981.0m−₩2.01bn−₩26.58bn₩23.83bn−₩3.10bn−₩2.47bn
Total assets₩47.95bn₩54.73bn₩50.39bn₩42.99bn₩43.56bn₩49.59bn₩50.18bn₩26.51bn
Cash and short-term investments—————₩30.57bn₩11.14bn₩12.46bn
Debt———₩300.0m₩600.0m₩8.06bn₩9.01bn₩9.58bn
Shareholders' equity₩35.69bn₩41.12bn₩36.11bn₩27.69bn₩26.56bn₩27.62bn₩30.69bn₩6.18bn

Financial ratios

Data as of 3 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-15.5%-48.4%-142.4%-187.6%-880.5%-773.3%—
Net margin-16.6%-50.3%-117.7%-189.3%-870.0%-883.6%—
Return on equity-16.0%-42.4%-311.3%-83.8%-86.6%305.0%—
Return on assets-11.5%-25.9%-69.3%-44.3%-54.9%-115.9%—
Revenue growth34.7%94.9%60.4%268.1%78.8%675.6%—
Earnings growth-55.6%-16.7%-0.2%-19.9%76.0%87.9%—
Current ratio3.05x2.52x1.31x1.72x3.16x1.17x—
Debt to equity—0.04x0.68x0.22x0.19x-1.15x0.00x
Equity ratio71.7%61.2%22.3%52.8%63.4%-38.0%—
Interest coverage-12.95x-21.55x-21.49x-42.06x-149.05x-180.65x—
R&D as a share of sales17.0%20.4%35.1%58.6%225.6%191.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue61.5%94.3%—
Operating income-29.6%-11.0%—
Net income-28.3%-12.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-54.1-25.8-30.8-4.5-10.8
Price to sales9.013.036.28.694.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.